$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 28/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 28/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | M | 30.63 | 13,000 | 398,190 | 13,736 | |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 639.55 | 79 | 50,524 | 41,951 | 42 K to 42 K (-0.19 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 638.96 | 239 | 152,711 | 42,030 | 42.3 K to 42 K (-0.57 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 637.48 | 182 | 116,021 | 42,269 | 42.5 K to 42.3 K (-0.43 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 635.46 | 175 | 111,206 | 42,451 | 42.6 K to 42.5 K (-0.41 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 634.18 | 89 | 56,442 | 42,626 | 42.7 K to 42.6 K (-0.21 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 633.02 | 95 | 60,137 | 42,715 | 42.8 K to 42.7 K (-0.22 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 632.12 | 679 | 429,209 | 42,810 | 43.5 K to 42.8 K (-1.56 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 631.32 | 578 | 364,903 | 43,489 | 44.1 K to 43.5 K (-1.31 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 630.77 | 264 | 166,523 | 44,067 | 44.3 K to 44.1 K (-0.60 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 629.58 | 852 | 536,402 | 44,331 | 45.2 K to 44.3 K (-1.89 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 628.50 | 950 | 597,075 | 45,183 | 46.1 K to 45.2 K (-2.06 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 626.66 | 83 | 52,013 | 46,133 | 46.2 K to 46.1 K (-0.18 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 625.05 | 4 | 2,500 | 46,216 | 46.2 K to 46.2 K (-0.01 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 624.77 | 487 | 304,263 | 46,220 | 46.7 K to 46.2 K (-1.04 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 622.51 | 1 | 623 | 46,707 | 46.7 K to 46.7 K (0.00 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 621.06 | 113 | 70,180 | 46,708 | 46.8 K to 46.7 K (-0.24 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 620.94 | 81 | 50,296 | 46,821 | 46.9 K to 46.8 K (-0.17 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 619.28 | 162 | 100,323 | 46,902 | 47.1 K to 46.9 K (-0.34 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 618.39 | 255 | 157,689 | 47,064 | 47.3 K to 47.1 K (-0.54 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 617.64 | 304 | 187,763 | 47,319 | 47.6 K to 47.3 K (-0.64 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 616.34 | 256 | 157,783 | 47,623 | 47.9 K to 47.6 K (-0.53 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 615.59 | 203 | 124,965 | 47,879 | 48.1 K to 47.9 K (-0.42 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 614.62 | 178 | 109,402 | 48,082 | 48.3 K to 48.1 K (-0.37 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Payment of Exercise | F | 623.98 | 6,691 | 4,175,050 | 48,260 | 55 K to 48.3 K (-12.18 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Buy | M | 30.63 | 13,000 | 398,190 | 54,951 | 42 K to 55 K (+30.99 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 633.28 | 441 | 279,276 | 41,951 | 42.4 K to 42 K (-1.04 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 632.65 | 680 | 430,202 | 42,392 | 43.1 K to 42.4 K (-1.58 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 631.45 | 861 | 543,678 | 43,072 | 43.9 K to 43.1 K (-1.96 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 630.50 | 1,423 | 897,202 | 43,933 | 45.4 K to 43.9 K (-3.14 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 629.62 | 883 | 555,954 | 45,356 | 46.2 K to 45.4 K (-1.91 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 628.32 | 259 | 162,735 | 46,239 | 46.5 K to 46.2 K (-0.56 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 627.54 | 657 | 412,294 | 46,498 | 47.2 K to 46.5 K (-1.39 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 626.63 | 1,003 | 628,510 | 47,155 | 48.2 K to 47.2 K (-2.08 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 625.86 | 173 | 108,274 | 48,158 | 48.3 K to 48.2 K (-0.36 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 624.47 | 370 | 231,054 | 48,331 | 48.7 K to 48.3 K (-0.76 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 623.66 | 740 | 461,508 | 48,701 | 49.4 K to 48.7 K (-1.50 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 622.74 | 333 | 207,372 | 49,441 | 49.8 K to 49.4 K (-0.67 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 621.98 | 81 | 50,380 | 49,774 | 49.9 K to 49.8 K (-0.16 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 620.64 | 96 | 59,581 | 49,855 | 50 K to 49.9 K (-0.19 %) |
Jul 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 640.50 | 579 | 370,850 | 23,973 | 24.6 K to 24 K (-2.36 %) |
Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 3,000 | 1,198,980 | 28,500 | |
Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 642.46 | 2,421 | 1,555,396 | 24,552 | 27 K to 24.6 K (-8.98 %) |
Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 3,000 | 1,198,980 | 26,973 | 24 K to 27 K (+12.51 %) |